Home › Funds › UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME › MRK

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME position in MRK

MERCK & CO INC · Health Care

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME reported holding 19,737,319 shares of MRK (MERCK & CO INC) in its Q3 2026 13F filing — a position valued at US$2.87B, representing 0.43% of its reported portfolio and ranking #37 among its reported holdings. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)19.74M sh
Reported value held$2.87B
Portfolio Weight0.43%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME's MRK position evolved

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME first disclosed a stake in MRK in Q3 2023 at 12,652,064 shares (US$1.30B). The position peaked in Q3 2026 at 19,737,319 shares, worth US$2.87B. Across 13 filings, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 19,737,319 shares valued at US$2.87B — an increase of 190,148 shares quarter over quarter.. Notable position changes include a 39% increase in Q2 2024 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.65M $1.30B New
Q4 2023 12.67M $1.38B Hold
Q1 2024 12.55M $1.66B Reduce
Q2 2024 17.45M $2.16B Add
Q3 2024 17.76M $2.02B Add
Q4 2024 21.55M $2.14B Add
Q1 2025 20.74M $1.86B Reduce
Q2 2025 25.13M $1.99B Add
Q3 2025 19.75M $1.66B Reduce
Q4 2025 19.43M $2.05B Reduce
Q1 2026 20.41M $2.46B Add
Q2 2026 19.55M $2.51B Reduce
Q3 2026 19.74M $2.87B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO INC) is a Health Care company. 29 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$33.14B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME held MRK?

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME's current position in MRK?

As of Q3 2026, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME holds 19.74M shares of MRK (MERCK & CO INC), valued at $2.87B, representing 0.43% of its reported portfolio and ranking #37.

Has UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME been buying or selling MRK?

In the latest 13F filing (Q3 2026), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME increased its position in MRK. The position peaked in Q3 2026 at 19.74M shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.